Xianzhong Meng
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve | 40 | 2023 | 396 | 11.440 |
Why?
| Aortic Valve Stenosis | 30 | 2023 | 269 | 8.450 |
Why?
| Calcinosis | 22 | 2022 | 239 | 6.300 |
Why?
| Toll-Like Receptor 4 | 32 | 2021 | 285 | 6.260 |
Why?
| Osteogenesis | 17 | 2022 | 181 | 4.910 |
Why?
| Toll-Like Receptor 2 | 12 | 2022 | 110 | 3.530 |
Why?
| NF-kappa B | 25 | 2022 | 636 | 3.100 |
Why?
| Intercellular Adhesion Molecule-1 | 17 | 2022 | 147 | 2.720 |
Why?
| Bone Morphogenetic Protein 2 | 14 | 2018 | 74 | 2.470 |
Why?
| Cells, Cultured | 37 | 2023 | 3861 | 2.240 |
Why?
| Myocardium | 12 | 2017 | 911 | 2.020 |
Why?
| Monocytes | 3 | 2022 | 503 | 1.860 |
Why?
| Glucuronidase | 3 | 2020 | 42 | 1.790 |
Why?
| Heart Valve Diseases | 5 | 2020 | 161 | 1.770 |
Why?
| Interleukin-1 | 6 | 2023 | 965 | 1.760 |
Why?
| Endotoxemia | 7 | 2017 | 86 | 1.670 |
Why?
| Myocardial Reperfusion Injury | 5 | 2015 | 95 | 1.540 |
Why?
| Lipoproteins, LDL | 5 | 2017 | 127 | 1.530 |
Why?
| Up-Regulation | 14 | 2020 | 802 | 1.510 |
Why?
| Biglycan | 4 | 2017 | 7 | 1.500 |
Why?
| Signal Transduction | 30 | 2023 | 4501 | 1.420 |
Why?
| Reperfusion Injury | 8 | 2022 | 252 | 1.310 |
Why?
| Interleukins | 4 | 2022 | 236 | 1.270 |
Why?
| Receptor, Notch1 | 3 | 2014 | 59 | 1.260 |
Why?
| Neurotrophin 3 | 2 | 2020 | 11 | 1.250 |
Why?
| Proto-Oncogene Proteins c-akt | 5 | 2020 | 397 | 1.240 |
Why?
| Matrilin Proteins | 4 | 2022 | 7 | 1.240 |
Why?
| Myofibroblasts | 4 | 2018 | 115 | 1.180 |
Why?
| Inflammation Mediators | 4 | 2022 | 475 | 1.160 |
Why?
| Lipopolysaccharides | 17 | 2020 | 813 | 1.130 |
Why?
| Heart | 8 | 2017 | 613 | 1.120 |
Why?
| Tumor Necrosis Factor-alpha | 9 | 2013 | 1128 | 1.110 |
Why?
| Transforming Growth Factor beta1 | 3 | 2017 | 153 | 1.080 |
Why?
| Down-Regulation | 6 | 2020 | 594 | 0.990 |
Why?
| Matrix Metalloproteinases | 2 | 2017 | 89 | 0.990 |
Why?
| Vascular Calcification | 2 | 2017 | 106 | 0.980 |
Why?
| Coronary Vessels | 2 | 2021 | 234 | 0.970 |
Why?
| Esophageal Neoplasms | 10 | 2022 | 270 | 0.960 |
Why?
| Collagen | 4 | 2022 | 414 | 0.950 |
Why?
| Chemokine CCL2 | 5 | 2017 | 104 | 0.940 |
Why?
| Recombinant Proteins | 10 | 2023 | 1228 | 0.930 |
Why?
| Inflammation | 10 | 2021 | 2464 | 0.910 |
Why?
| Spinal Cord Ischemia | 8 | 2018 | 63 | 0.890 |
Why?
| MicroRNAs | 3 | 2019 | 600 | 0.890 |
Why?
| Endothelial Cells | 3 | 2021 | 677 | 0.860 |
Why?
| Extracellular Matrix Proteins | 3 | 2021 | 126 | 0.800 |
Why?
| Chemokines | 4 | 2015 | 215 | 0.780 |
Why?
| Heart Diseases | 2 | 2022 | 329 | 0.780 |
Why?
| Anti-Inflammatory Agents | 3 | 2023 | 445 | 0.770 |
Why?
| Group II Phospholipases A2 | 7 | 2020 | 16 | 0.750 |
Why?
| Adenocarcinoma | 10 | 2022 | 787 | 0.750 |
Why?
| Mitogen-Activated Protein Kinase 1 | 4 | 2020 | 164 | 0.730 |
Why?
| Receptor, trkA | 2 | 2020 | 16 | 0.730 |
Why?
| Mice, Inbred C57BL | 22 | 2022 | 4680 | 0.730 |
Why?
| HSP70 Heat-Shock Proteins | 4 | 2017 | 61 | 0.730 |
Why?
| Mitogen-Activated Protein Kinase 3 | 4 | 2021 | 145 | 0.710 |
Why?
| Disease Susceptibility | 1 | 2022 | 316 | 0.680 |
Why?
| Animals | 47 | 2023 | 31565 | 0.680 |
Why?
| Osteoblasts | 2 | 2017 | 106 | 0.660 |
Why?
| Aging | 3 | 2022 | 1611 | 0.660 |
Why?
| Phospholipases A2, Secretory | 6 | 2019 | 21 | 0.650 |
Why?
| Mice | 36 | 2023 | 14841 | 0.650 |
Why?
| Alkaline Phosphatase | 7 | 2019 | 142 | 0.640 |
Why?
| Male | 50 | 2022 | 55396 | 0.640 |
Why?
| HSC70 Heat-Shock Proteins | 2 | 2009 | 4 | 0.630 |
Why?
| Toll-Like Receptor 3 | 2 | 2017 | 26 | 0.630 |
Why?
| Gastroesophageal Reflux | 6 | 2022 | 229 | 0.630 |
Why?
| Myeloid Differentiation Factor 88 | 3 | 2020 | 90 | 0.620 |
Why?
| Humans | 68 | 2023 | 114043 | 0.610 |
Why?
| Myocardial Contraction | 3 | 2008 | 318 | 0.600 |
Why?
| Middle Aged | 25 | 2022 | 26605 | 0.600 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 373 | 0.600 |
Why?
| Barrett Esophagus | 5 | 2022 | 143 | 0.580 |
Why?
| Heart Defects, Congenital | 3 | 2020 | 683 | 0.580 |
Why?
| ADAMTS5 Protein | 1 | 2017 | 5 | 0.570 |
Why?
| Neutrophil Infiltration | 3 | 2009 | 94 | 0.560 |
Why?
| Cell Transdifferentiation | 1 | 2017 | 31 | 0.560 |
Why?
| SOX9 Transcription Factor | 1 | 2017 | 23 | 0.560 |
Why?
| Lysophosphatidylcholines | 1 | 2017 | 20 | 0.560 |
Why?
| Core Binding Factor Alpha 1 Subunit | 7 | 2023 | 40 | 0.560 |
Why?
| Cyclin D1 | 1 | 2017 | 61 | 0.560 |
Why?
| HSP27 Heat-Shock Proteins | 2 | 2014 | 11 | 0.550 |
Why?
| Cell Proliferation | 11 | 2020 | 2173 | 0.550 |
Why?
| RNA, Double-Stranded | 1 | 2017 | 44 | 0.540 |
Why?
| Epigenesis, Genetic | 2 | 2017 | 517 | 0.520 |
Why?
| Phosphates | 1 | 2017 | 155 | 0.520 |
Why?
| RNA Interference | 6 | 2017 | 431 | 0.510 |
Why?
| Aged | 16 | 2019 | 18969 | 0.510 |
Why?
| Immunity, Innate | 3 | 2019 | 720 | 0.510 |
Why?
| Vascular Cell Adhesion Molecule-1 | 4 | 2022 | 35 | 0.500 |
Why?
| Extracellular Space | 3 | 2010 | 116 | 0.490 |
Why?
| Enzyme Inhibitors | 6 | 2020 | 743 | 0.460 |
Why?
| Ventricular Function, Left | 1 | 2017 | 477 | 0.440 |
Why?
| Immune Tolerance | 2 | 2019 | 321 | 0.440 |
Why?
| Myocarditis | 3 | 2011 | 93 | 0.430 |
Why?
| Simvastatin | 5 | 2022 | 58 | 0.430 |
Why?
| Receptors, Erythropoietin | 3 | 2018 | 22 | 0.420 |
Why?
| Myocardial Ischemia | 3 | 2011 | 239 | 0.410 |
Why?
| Mice, Knockout | 9 | 2017 | 2562 | 0.400 |
Why?
| Interleukin-6 | 5 | 2022 | 673 | 0.390 |
Why?
| Erythropoietin | 3 | 2018 | 72 | 0.380 |
Why?
| Esophagus | 4 | 2020 | 224 | 0.380 |
Why?
| Spinal Cord | 5 | 2018 | 344 | 0.370 |
Why?
| Cytokines | 7 | 2017 | 1824 | 0.360 |
Why?
| Matrix Metalloproteinase 9 | 2 | 2022 | 118 | 0.350 |
Why?
| Mice, Inbred C3H | 6 | 2021 | 242 | 0.350 |
Why?
| Interleukin-1beta | 2 | 2013 | 368 | 0.350 |
Why?
| Transfection | 5 | 2017 | 863 | 0.340 |
Why?
| Case-Control Studies | 5 | 2017 | 3003 | 0.340 |
Why?
| Gene Knockdown Techniques | 3 | 2017 | 301 | 0.340 |
Why?
| Shock, Hemorrhagic | 3 | 2012 | 152 | 0.330 |
Why?
| Lung Neoplasms | 7 | 2019 | 2159 | 0.330 |
Why?
| Endotoxins | 1 | 2010 | 211 | 0.320 |
Why?
| Lipopeptides | 2 | 2020 | 14 | 0.320 |
Why?
| Female | 16 | 2022 | 59325 | 0.320 |
Why?
| Actins | 3 | 2017 | 376 | 0.310 |
Why?
| Actin Cytoskeleton | 1 | 2009 | 93 | 0.310 |
Why?
| Calcium-Binding Proteins | 3 | 2015 | 205 | 0.300 |
Why?
| Receptors, Cell Surface | 3 | 2004 | 350 | 0.290 |
Why?
| Ventricular Dysfunction, Left | 2 | 2008 | 371 | 0.290 |
Why?
| Disease Models, Animal | 13 | 2022 | 3498 | 0.290 |
Why?
| Esophagitis, Peptic | 2 | 2022 | 16 | 0.280 |
Why?
| Phenotype | 7 | 2017 | 2784 | 0.280 |
Why?
| p38 Mitogen-Activated Protein Kinases | 5 | 2018 | 249 | 0.270 |
Why?
| RNA, Small Interfering | 3 | 2014 | 534 | 0.250 |
Why?
| Immunoblotting | 3 | 2017 | 282 | 0.250 |
Why?
| Dexmedetomidine | 3 | 2014 | 45 | 0.240 |
Why?
| Interleukin-18 | 2 | 2006 | 217 | 0.240 |
Why?
| Carcinoma, Non-Small-Cell Lung | 4 | 2014 | 959 | 0.240 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 73 | 0.230 |
Why?
| Ischemia | 2 | 2022 | 361 | 0.230 |
Why?
| Biomarkers | 4 | 2022 | 3397 | 0.230 |
Why?
| Gene Expression Regulation | 6 | 2017 | 2321 | 0.230 |
Why?
| Intercellular Signaling Peptides and Proteins | 3 | 2013 | 347 | 0.230 |
Why?
| Neuroprotective Agents | 2 | 2018 | 102 | 0.220 |
Why?
| Enzyme-Linked Immunosorbent Assay | 6 | 2017 | 787 | 0.220 |
Why?
| Apoptosis | 5 | 2018 | 2349 | 0.220 |
Why?
| Adrenergic alpha-2 Receptor Agonists | 2 | 2014 | 24 | 0.220 |
Why?
| Spinal Cord Injuries | 2 | 2018 | 173 | 0.220 |
Why?
| Phosphorylation | 5 | 2013 | 1558 | 0.210 |
Why?
| Mice, Transgenic | 3 | 2017 | 1947 | 0.210 |
Why?
| Jagged-1 Protein | 2 | 2013 | 22 | 0.210 |
Why?
| Serrate-Jagged Proteins | 2 | 2013 | 27 | 0.210 |
Why?
| Fluorescent Antibody Technique | 7 | 2010 | 396 | 0.210 |
Why?
| MAP Kinase Signaling System | 2 | 2015 | 271 | 0.210 |
Why?
| Receptors, Interleukin-9 | 1 | 2022 | 2 | 0.210 |
Why?
| Smad1 Protein | 2 | 2014 | 18 | 0.200 |
Why?
| CD18 Antigens | 1 | 2022 | 25 | 0.200 |
Why?
| Infarction | 1 | 2022 | 12 | 0.200 |
Why?
| Neoplasm Proteins | 2 | 2019 | 385 | 0.200 |
Why?
| Heat-Shock Proteins | 2 | 2014 | 112 | 0.190 |
Why?
| Tumor Burden | 2 | 2020 | 258 | 0.190 |
Why?
| Culture Media, Conditioned | 1 | 2022 | 103 | 0.190 |
Why?
| Diazoxide | 2 | 2018 | 22 | 0.190 |
Why?
| Microglia | 2 | 2013 | 198 | 0.190 |
Why?
| Lab-On-A-Chip Devices | 1 | 2021 | 30 | 0.190 |
Why?
| Time Factors | 7 | 2014 | 6077 | 0.190 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 924 | 0.190 |
Why?
| Caspases | 1 | 2022 | 243 | 0.190 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 144 | 0.190 |
Why?
| Inflammasomes | 1 | 2022 | 115 | 0.180 |
Why?
| Pentanoic Acids | 1 | 2020 | 2 | 0.180 |
Why?
| In Vitro Techniques | 3 | 2009 | 1003 | 0.180 |
Why?
| Gene Expression | 4 | 2009 | 1417 | 0.180 |
Why?
| Mice, Inbred NOD | 1 | 2022 | 552 | 0.180 |
Why?
| Adaptor Proteins, Vesicular Transport | 2 | 2019 | 44 | 0.180 |
Why?
| Dinoprostone | 2 | 2019 | 183 | 0.170 |
Why?
| Indole Alkaloids | 1 | 2020 | 9 | 0.170 |
Why?
| eIF-2 Kinase | 1 | 2020 | 24 | 0.170 |
Why?
| Primary Cell Culture | 2 | 2018 | 148 | 0.170 |
Why?
| STAT3 Transcription Factor | 3 | 2019 | 172 | 0.170 |
Why?
| Cell Line, Tumor | 9 | 2020 | 2698 | 0.170 |
Why?
| Carbazoles | 1 | 2020 | 76 | 0.170 |
Why?
| Blotting, Western | 7 | 2020 | 1143 | 0.160 |
Why?
| Wnt Signaling Pathway | 1 | 2020 | 146 | 0.160 |
Why?
| Cell Movement | 2 | 2014 | 863 | 0.160 |
Why?
| Matrix Metalloproteinase 12 | 1 | 2018 | 6 | 0.160 |
Why?
| Cell Adhesion Molecules | 2 | 2021 | 167 | 0.160 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 1142 | 0.150 |
Why?
| RNA, Neoplasm | 1 | 2018 | 80 | 0.150 |
Why?
| Cell Line | 3 | 2020 | 2629 | 0.150 |
Why?
| Heme Oxygenase-1 | 2 | 2009 | 51 | 0.150 |
Why?
| Neutrophils | 6 | 2012 | 1089 | 0.150 |
Why?
| Calcium | 2 | 2022 | 1089 | 0.140 |
Why?
| Sp7 Transcription Factor | 1 | 2017 | 7 | 0.140 |
Why?
| Antagomirs | 1 | 2017 | 13 | 0.140 |
Why?
| Sclerosis | 1 | 2017 | 11 | 0.140 |
Why?
| Toll-Like Receptors | 2 | 2017 | 167 | 0.140 |
Why?
| Mice, Mutant Strains | 2 | 2008 | 271 | 0.140 |
Why?
| Collagen Type III | 1 | 2017 | 15 | 0.140 |
Why?
| Poly I-C | 1 | 2017 | 51 | 0.140 |
Why?
| Mice, Inbred Strains | 3 | 2008 | 398 | 0.140 |
Why?
| Membrane Proteins | 2 | 2013 | 1016 | 0.140 |
Why?
| NFATC Transcription Factors | 1 | 2017 | 78 | 0.140 |
Why?
| Adult | 10 | 2018 | 30375 | 0.130 |
Why?
| Cattle | 2 | 2010 | 918 | 0.130 |
Why?
| Collagen Type I | 1 | 2017 | 108 | 0.130 |
Why?
| Biomarkers, Tumor | 2 | 2020 | 1032 | 0.130 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 139 | 0.130 |
Why?
| RNA, Messenger | 8 | 2012 | 2550 | 0.130 |
Why?
| Dose-Response Relationship, Drug | 6 | 2020 | 1836 | 0.130 |
Why?
| Molecular Chaperones | 2 | 2014 | 156 | 0.120 |
Why?
| Macrophages | 4 | 2011 | 1259 | 0.120 |
Why?
| Protein Kinase C | 1 | 2017 | 271 | 0.120 |
Why?
| Mucous Membrane | 3 | 2010 | 108 | 0.120 |
Why?
| Enzyme Activation | 3 | 2013 | 771 | 0.120 |
Why?
| Models, Biological | 1 | 2022 | 1611 | 0.120 |
Why?
| Smad3 Protein | 1 | 2014 | 41 | 0.120 |
Why?
| Cardiovascular Surgical Procedures | 1 | 2014 | 29 | 0.120 |
Why?
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 152 | 0.120 |
Why?
| Paraplegia | 2 | 2011 | 52 | 0.110 |
Why?
| Protein Binding | 2 | 2010 | 1888 | 0.110 |
Why?
| Solubility | 1 | 2014 | 223 | 0.110 |
Why?
| Microfilament Proteins | 1 | 2014 | 125 | 0.110 |
Why?
| Mice, Inbred BALB C | 4 | 2010 | 1144 | 0.110 |
Why?
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2013 | 5 | 0.110 |
Why?
| Duodenogastric Reflux | 2 | 2010 | 2 | 0.110 |
Why?
| Drug Evaluation, Preclinical | 3 | 2020 | 159 | 0.110 |
Why?
| Calcium Phosphates | 1 | 2013 | 24 | 0.110 |
Why?
| Osteopontin | 2 | 2012 | 32 | 0.110 |
Why?
| Astrocytes | 1 | 2014 | 159 | 0.110 |
Why?
| Dipeptides | 1 | 2012 | 47 | 0.100 |
Why?
| Arachidonate 5-Lipoxygenase | 1 | 2012 | 43 | 0.100 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2012 | 72 | 0.100 |
Why?
| Lung | 5 | 2012 | 3521 | 0.100 |
Why?
| ras Proteins | 1 | 2012 | 138 | 0.100 |
Why?
| Deoxycholic Acid | 2 | 2021 | 15 | 0.090 |
Why?
| Diiodothyronines | 1 | 2011 | 3 | 0.090 |
Why?
| Antineoplastic Agents | 2 | 2012 | 1875 | 0.090 |
Why?
| Protein Kinase Inhibitors | 1 | 2017 | 784 | 0.090 |
Why?
| Radiation Injuries | 1 | 2012 | 128 | 0.090 |
Why?
| Propionates | 1 | 2011 | 34 | 0.090 |
Why?
| Motor Activity | 2 | 2013 | 635 | 0.090 |
Why?
| Antibodies, Neutralizing | 2 | 2012 | 222 | 0.090 |
Why?
| Aorta, Abdominal | 1 | 2011 | 39 | 0.090 |
Why?
| Genetic Therapy | 1 | 2012 | 256 | 0.090 |
Why?
| Cardiomyopathies | 1 | 2014 | 298 | 0.090 |
Why?
| Neoplastic Stem Cells | 1 | 2014 | 327 | 0.090 |
Why?
| Endothelium, Vascular | 1 | 2017 | 830 | 0.090 |
Why?
| Ischemic Preconditioning, Myocardial | 1 | 2010 | 29 | 0.090 |
Why?
| Antibodies | 2 | 2002 | 365 | 0.090 |
Why?
| Heart Function Tests | 1 | 2010 | 60 | 0.090 |
Why?
| Interleukin-8 | 2 | 2008 | 229 | 0.090 |
Why?
| Cell Survival | 4 | 2014 | 1014 | 0.090 |
Why?
| A549 Cells | 2 | 2020 | 51 | 0.080 |
Why?
| Actinin | 1 | 2009 | 13 | 0.080 |
Why?
| Acute Lung Injury | 1 | 2012 | 268 | 0.080 |
Why?
| Proto-Oncogene Proteins | 1 | 2012 | 607 | 0.080 |
Why?
| Mutation | 2 | 2012 | 3338 | 0.080 |
Why?
| Polymerization | 1 | 2009 | 119 | 0.080 |
Why?
| Phospholipases A2 | 1 | 2008 | 73 | 0.080 |
Why?
| Ventricular Pressure | 1 | 2008 | 39 | 0.080 |
Why?
| beta Catenin | 2 | 2021 | 218 | 0.070 |
Why?
| Random Allocation | 3 | 2020 | 328 | 0.070 |
Why?
| Peptidoglycan | 1 | 2007 | 25 | 0.070 |
Why?
| Myocardial Depressant Factor | 1 | 2007 | 2 | 0.070 |
Why?
| Perfusion | 1 | 2008 | 147 | 0.070 |
Why?
| Lower Extremity | 1 | 2011 | 334 | 0.070 |
Why?
| Oxyhemoglobins | 1 | 2007 | 20 | 0.070 |
Why?
| Carcinoma, Squamous Cell | 1 | 2012 | 577 | 0.070 |
Why?
| Blood Substitutes | 1 | 2007 | 22 | 0.070 |
Why?
| Pulmonary Valve | 1 | 2009 | 89 | 0.070 |
Why?
| Kupffer Cells | 1 | 2007 | 45 | 0.070 |
Why?
| Analysis of Variance | 4 | 2012 | 1218 | 0.070 |
Why?
| Hemoglobins | 1 | 2009 | 308 | 0.070 |
Why?
| Hyperplasia | 2 | 2010 | 163 | 0.070 |
Why?
| Bone Morphogenetic Proteins | 1 | 2007 | 132 | 0.070 |
Why?
| Cell Transformation, Neoplastic | 1 | 2008 | 307 | 0.060 |
Why?
| Caspase 1 | 1 | 2006 | 140 | 0.060 |
Why?
| Protein Structure, Tertiary | 1 | 2008 | 796 | 0.060 |
Why?
| Mice, Nude | 2 | 2020 | 628 | 0.060 |
Why?
| Cell Culture Techniques | 2 | 2019 | 341 | 0.060 |
Why?
| Transforming Growth Factor beta | 1 | 2007 | 445 | 0.060 |
Why?
| Binding Sites | 1 | 2008 | 1166 | 0.060 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2020 | 695 | 0.060 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2004 | 34 | 0.060 |
Why?
| Disease Progression | 2 | 2020 | 2371 | 0.060 |
Why?
| Glutamine | 1 | 2005 | 91 | 0.060 |
Why?
| Myocardial Infarction | 1 | 2011 | 932 | 0.060 |
Why?
| Microscopy, Fluorescence | 2 | 2018 | 393 | 0.060 |
Why?
| DNA | 1 | 2010 | 1350 | 0.050 |
Why?
| Mycobacterium tuberculosis | 1 | 2006 | 269 | 0.050 |
Why?
| Immunohistochemistry | 4 | 2009 | 1624 | 0.050 |
Why?
| Interferon-gamma | 1 | 2006 | 719 | 0.050 |
Why?
| Cell Adhesion | 2 | 2020 | 426 | 0.050 |
Why?
| Vinblastine | 1 | 2002 | 63 | 0.050 |
Why?
| Leukocyte Elastase | 1 | 2002 | 71 | 0.050 |
Why?
| Carotid Artery Injuries | 1 | 2002 | 44 | 0.050 |
Why?
| Tunica Intima | 1 | 2002 | 78 | 0.050 |
Why?
| Adenosine Triphosphatases | 1 | 2023 | 152 | 0.050 |
Why?
| Annexin A5 | 1 | 2022 | 22 | 0.050 |
Why?
| Chemotactic Factors | 1 | 2002 | 50 | 0.050 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 438 | 0.050 |
Why?
| Chemokines, CXC | 1 | 2002 | 60 | 0.050 |
Why?
| Peroxidase | 3 | 2012 | 161 | 0.050 |
Why?
| Cell Count | 1 | 2002 | 303 | 0.050 |
Why?
| Growth Substances | 1 | 2002 | 138 | 0.050 |
Why?
| Magnetic Resonance Spectroscopy | 2 | 2019 | 474 | 0.050 |
Why?
| Flow Cytometry | 3 | 2011 | 1075 | 0.050 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2002 | 181 | 0.050 |
Why?
| Caspase 3 | 1 | 2022 | 234 | 0.050 |
Why?
| Receptors, Interleukin-1 | 1 | 2002 | 228 | 0.050 |
Why?
| Drosophila Proteins | 1 | 2002 | 164 | 0.040 |
Why?
| Postoperative Complications | 1 | 2011 | 2122 | 0.040 |
Why?
| Tissue Banks | 1 | 2020 | 17 | 0.040 |
Why?
| Warfarin | 1 | 2021 | 136 | 0.040 |
Why?
| Esophageal Mucosa | 1 | 2020 | 17 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2002 | 429 | 0.040 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2018 | 5 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2011 | 845 | 0.040 |
Why?
| Fibrosis | 1 | 2020 | 452 | 0.040 |
Why?
| Receptor, ErbB-2 | 1 | 2020 | 300 | 0.040 |
Why?
| Protein Multimerization | 1 | 2019 | 157 | 0.040 |
Why?
| Brain | 1 | 2009 | 2355 | 0.040 |
Why?
| Crystallography, X-Ray | 1 | 2019 | 402 | 0.040 |
Why?
| ErbB Receptors | 1 | 2020 | 554 | 0.030 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 2182 | 0.030 |
Why?
| Sepsis | 1 | 2002 | 507 | 0.030 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2012 | 580 | 0.030 |
Why?
| Cardiomyopathy, Dilated | 1 | 2018 | 350 | 0.030 |
Why?
| Tensins | 1 | 2014 | 2 | 0.030 |
Why?
| Aminosalicylic Acids | 1 | 2014 | 5 | 0.030 |
Why?
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2014 | 16 | 0.030 |
Why?
| Benzenesulfonates | 1 | 2014 | 19 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2014 | 160 | 0.030 |
Why?
| Sensitivity and Specificity | 2 | 2008 | 1690 | 0.030 |
Why?
| Foscarnet | 1 | 2013 | 18 | 0.030 |
Why?
| Rats | 3 | 2009 | 4913 | 0.030 |
Why?
| Nerve Degeneration | 1 | 2013 | 41 | 0.030 |
Why?
| Minocycline | 1 | 2013 | 26 | 0.030 |
Why?
| Cell Growth Processes | 1 | 2012 | 51 | 0.030 |
Why?
| Leukotriene C4 | 1 | 2012 | 12 | 0.030 |
Why?
| Leukotriene B4 | 1 | 2012 | 42 | 0.030 |
Why?
| Ki-67 Antigen | 1 | 2012 | 102 | 0.030 |
Why?
| Monokines | 2 | 2002 | 24 | 0.030 |
Why?
| Lipoxygenase Inhibitors | 1 | 2012 | 36 | 0.020 |
Why?
| Chemokine CXCL2 | 2 | 2002 | 41 | 0.020 |
Why?
| Heart Transplantation | 1 | 2018 | 670 | 0.020 |
Why?
| Eicosanoids | 1 | 2012 | 54 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 157 | 0.020 |
Why?
| Pravastatin | 1 | 2011 | 28 | 0.020 |
Why?
| Radiotherapy | 1 | 2012 | 175 | 0.020 |
Why?
| Heptanoic Acids | 1 | 2011 | 60 | 0.020 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 228 | 0.020 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 270 | 0.020 |
Why?
| Constriction | 1 | 2011 | 45 | 0.020 |
Why?
| Culture Media | 1 | 2011 | 155 | 0.020 |
Why?
| Subclavian Artery | 1 | 2011 | 29 | 0.020 |
Why?
| Pyrroles | 1 | 2011 | 181 | 0.020 |
Why?
| Hindlimb | 1 | 2011 | 130 | 0.020 |
Why?
| Indoles | 1 | 2012 | 300 | 0.020 |
Why?
| Molecular Targeted Therapy | 1 | 2012 | 347 | 0.020 |
Why?
| Glucose | 1 | 2014 | 899 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2012 | 1162 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2011 | 521 | 0.020 |
Why?
| Prospective Studies | 1 | 2020 | 6195 | 0.020 |
Why?
| Hypoxia | 1 | 2014 | 956 | 0.020 |
Why?
| Acute Disease | 1 | 2011 | 907 | 0.020 |
Why?
| Organ Specificity | 1 | 2009 | 266 | 0.020 |
Why?
| Aorta, Thoracic | 1 | 2011 | 257 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2009 | 370 | 0.020 |
Why?
| Tissue and Organ Harvesting | 1 | 2008 | 62 | 0.020 |
Why?
| Treatment Outcome | 1 | 2021 | 9049 | 0.020 |
Why?
| Biopsy, Needle | 1 | 2008 | 180 | 0.020 |
Why?
| Cell Division | 1 | 2009 | 754 | 0.020 |
Why?
| Confidence Intervals | 1 | 2008 | 302 | 0.020 |
Why?
| Age Factors | 1 | 2014 | 2885 | 0.020 |
Why?
| HSP72 Heat-Shock Proteins | 1 | 2007 | 26 | 0.020 |
Why?
| Probability | 1 | 2008 | 286 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 2247 | 0.020 |
Why?
| Precancerous Conditions | 1 | 2008 | 155 | 0.020 |
Why?
| Quercetin | 1 | 2005 | 11 | 0.020 |
Why?
| Protein Isoforms | 1 | 2006 | 337 | 0.020 |
Why?
| Lymphocytes | 1 | 2006 | 327 | 0.010 |
Why?
| Epithelial Cells | 1 | 2010 | 946 | 0.010 |
Why?
| Dendritic Cells | 1 | 2006 | 435 | 0.010 |
Why?
| Group IB Phospholipases A2 | 1 | 2002 | 1 | 0.010 |
Why?
| Receptors, Phospholipase A2 | 1 | 2002 | 1 | 0.010 |
Why?
| Oxygen | 1 | 2007 | 851 | 0.010 |
Why?
| Chelating Agents | 1 | 2002 | 61 | 0.010 |
Why?
| Binding, Competitive | 1 | 2002 | 192 | 0.010 |
Why?
| Phospholipases A | 1 | 2002 | 95 | 0.010 |
Why?
| Chemokine CXCL1 | 1 | 2002 | 67 | 0.010 |
Why?
| Infant | 1 | 2014 | 7943 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2011 | 1468 | 0.010 |
Why?
| Sialoglycoproteins | 1 | 2002 | 158 | 0.010 |
Why?
| Cell Separation | 1 | 2002 | 290 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2002 | 269 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 9114 | 0.010 |
Why?
| Carotid Arteries | 1 | 2002 | 180 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 2002 | 298 | 0.010 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 253 | 0.010 |
Why?
| Trachea | 1 | 2002 | 223 | 0.010 |
Why?
| Salmonella typhimurium | 1 | 2002 | 165 | 0.010 |
Why?
| Risk Factors | 1 | 2013 | 8614 | 0.010 |
Why?
| Pulmonary Alveoli | 1 | 2002 | 372 | 0.010 |
Why?
| Cell Membrane | 1 | 2002 | 670 | 0.010 |
Why?
| Escherichia coli | 1 | 2002 | 723 | 0.010 |
Why?
| Young Adult | 1 | 2013 | 10444 | 0.010 |
Why?
| Adolescent | 1 | 2014 | 17800 | 0.010 |
Why?
| Liver | 1 | 2002 | 1633 | 0.010 |
Why?
|
|
Meng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|